N

NovaBay Pharmaceuticals
D

NBY

0.66010
USD
0.05
(8.21%)
مغلق
حجم التداول
497
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
3,839,276
أصول ذات صلة
ABT
ABT
-11.200
(-8.50%)
120.550 USD
AZN
AZN
-0.820
(-1.17%)
69.260 USD
GSK
GSK
-1.790
(-4.67%)
36.500 USD
JNJ
JNJ
-1.690
(-1.03%)
163.070 USD
MRK
MRK
-0.930
(-1.13%)
81.510 USD
NVS
NVS
-3.960
(-3.34%)
114.520 USD
PFE
PFE
0.005
(0.02%)
24.595 USD
P
PLX
0.07500
(5.26%)
1.50000 USD
SNY
SNY
0.125
(0.26%)
48.640 USD
المزيد
الأخبار المقالات

العنوان: NovaBay Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.